To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients
Clinical trial NCT01301898 · COMPLETED
Trial details
- NCT number
- NCT01301898
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-03-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.